Overview

CeraVe Diabetes Mellitus

Status:
Recruiting

Trial end date:
2022-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of the CeraVe Diabetic Skin Line for the improvement of skin condition in patients with diabetes mellitus.

Phase:

Phase 4

Details

Lead Sponsor:

University of Miami

Collaborator:

CeraVe

Treatments:

Dimenhydrinate